Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect on thrombin generation of oral contraceptives containing drospirenone in women with polycystic ovary syndrome
TCTR20250313004Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of drospirenone in polycystic ovary syndrome (PCOS), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
drospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on TCTR20250313004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250313004.